Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Nurofen survey reveals the ‘growing pains’ of children and teens

A Nurofen-funded survey has revealed the pains and emotional challenges faced by children aged 7-15, manufacturer Reckitt Benckiser (RB) has said.

The OnePoll survey – which received 2,000 responses, 1,000 of whom were from children – found that 48% of “tweens” aged 7-11 find growing up “scary at times”.

The survey, which ran between October 31 and November 5 last year, also found that more than half of those aged 12-15 feel under pressure at school due to homework, while nearly half worry about global issues such as climate change, RB said.

Almost a quarter of parents said their children find syrups too childish, while 40% said their children struggle to swallow pain relief tablets.

Nurofen senior brand manager Marcella Christophersen said: “Recognising the pain relief needs of this age group, we have recently launched two products to help overcome some of these practical challenges.”

The products are Nurofen for Children 200mg/5ml oral suspension, which is available in orange and strawberry flavours, and Nurofen Meltlets 200mg Orodispersible Tablets, available in orange and mint.

The products retail at £5.99 and £3.99 respectively.

For more information on Nurofen products, visit the brand’s website.

Do you often help children with "growing pains"?

Related Content

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD006271

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel